Partnership to include the Feinstein Institute, Cold Spring Harbor Lab, Penn Medicine, Temple University, and Israel Brain Technologies
MANHASSET, N.Y., Dec. 16, 2013 /PRNewswire-USNewswire/ -- Today, Congressmen Steve Israel (D-NY) and Chaka Fattah (D-PA) announced the signing of a Memorandum of Understanding (MOU) dedicated to creating a partnership in neuroscience research, and in particular, research on Alzheimer's disease. Signers of the MOU included the Feinstein Institute in Manhasset, Cold Spring Harbor Lab in Cold Spring Harbor, Penn Medicine in Philadelphia, Temple University in Philadelphia, and Israel Brain Technologies in Ramat Hasharon, Israel. Representatives from all the institutions were present. Both Reps. Israel and Fattah have been leaders in Congress on the issue of neuroscience and Alzheimer's research.
Rep. Israel said, "I was thrilled to join my colleague, Rep. Fattah, to announce a revolutionary global partnership between five world-class research institutions in neuroscience. I am confident that groundbreaking research will come from this partnership that will bring us closer to understanding the brain and finding a treatment, cure or prevention method for Alzheimer's disease. Both Rep. Fattah and I have been staunch advocates in Congress for more research for neuroscience and Alzheimer's disease, and today's announcement is an important step forward."
Rep. Fattah said, "Understanding that significant advancements in neuroscience require a sharing of resources, research, and strengthened communication, Rep. Israel and I are thrilled to see such a partnership formalized today. This is an international challenge that one organization or one country cannot solve on its own—rather it calls for global commitment, and most importantly, collaboration. Together these leading institutions from our districts, and Israel, will build extraordinary teams of researchers and doctors dedicated to discovering new treatments and cures. I look forward to joining them and Rep. Israel in our continued fight against brain disease."